IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms - Campos, Paula de Melo; Machado Neto, João Agostinho; Eide, Christopher A.; Savage, Samantha L.; Scopim-Ribeiro, Renata; Duarte, Adriana da Silva Souza; Favaro, Patrícia; Lorand-Metze, Irene; Costa, Fernando F.; Tognon, Cristina E.; Druker, Brian J.; Saad, Sara T. Olalla; et al. (Oncotarget, 2016)